secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001493152-23-016920
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab Q1 2023 revenue $352,799, up 32% sequentially; gross margin 53.1%
------------------------------------------------------------------------

- Net operating loss narrowed 17.1% to $120,758 from $145,701 in Q4 2022.
- Digital Medicine ISP service revenue surged 324% sequentially to $34,467.
- Allergy segment revenue increased 20% sequentially to $49,537.
- Management expects Digital Medicine ISP revenue to grow ~100% in Q2 2023.
- Gross margin target of +500 bps expansion for fiscal 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/0001493152-23-016920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-016920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer